Simvastatin-niacin combination, but not antioxidant vitamins, increased SAA levels in the HDL atherosclerosis treatment study (HATS)

被引：0
|
作者：
O'Brien, KD [1 ]
Morse, J [1 ]
Frutkin, A [1 ]
Baas, AS [1 ]
Brown, BG [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
CIRCULATION | 2002年 / 106卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
374
引用
收藏
页码：74 / 75
页数：2
相关论文
共 23 条
  • [1] Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL
    Cheung, MC
    Zhao, XQ
    Davis, JW
    Albers, JJ
    Chait, A
    Brown, BG
    CIRCULATION, 1998, 98 (17) : 452 - 452
  • [2] Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
    Brown, BG
    Zhao, XQ
    Chait, A
    Fisher, LD
    Cheung, MC
    Morse, JS
    Dowdy, AA
    Marino, EK
    Bolson, EL
    Alaupovic, P
    Frohlich, J
    Albers, JJ
    Serafini, L
    Huss-Frechette, E
    Wang, S
    DeAngelis, D
    Dodek, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22): : 1583 - 1592
  • [3] Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL
    Cheung, MC
    Zhao, XQ
    Chait, A
    Albers, JJ
    Brown, BG
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (08) : 1320 - 1326
  • [4] Simvastatin and niacin reduce high sensitivity c-reactive protein (HSCRP): Results from the hdl atherosclerosis treatment study (HATS).
    Frutkin, AD
    Baas, AS
    O'Brien, KD
    Morse, JS
    Zhao, XQ
    Brown, BG
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S175 - S175
  • [5] Levels of Cholesterol in Small LDL Particles Predict Atherosclerosis Progression and Incident CHD in the HDL-Atherosclerosis Treatment Study (HATS)
    Williams, Paul T.
    Zhao, Xue-Qiao
    Marcovina, Santica M.
    Brown, B. Greg
    Krauss, Ronald M.
    PLOS ONE, 2013, 8 (02):
  • [6] Niacin plus simvastatin, but not antioxidant vitamins, protect against atherosclerosis and clinical events in CAD patients with low HDLC.
    Brown, BG
    Zhao, XQ
    Chait, A
    Fisher, LD
    Dowdy, A
    Cheung, M
    Morse, JJ
    Serafini, L
    Huss-Frechette, E
    Deangelis, D
    Frohlich, JJ
    Albers, JJ
    CIRCULATION, 2000, 102 (18) : 506 - 506
  • [7] Reduction in high sensitivity c-reactive protein (hsCRP) during simvastatin and niacin therapy correlates with angiographic change in coronary artery stenosis: Results from the HDL atherosclerosis treatment study (HATS)
    Frutkin, AD
    Baas, A
    O'Brien, KD
    Morse, JS
    Brown, BG
    CIRCULATION, 2003, 108 (17) : 590 - 591
  • [8] Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study design
    Brown, BG
    Zhao, XQ
    Chait, A
    Frohlich, J
    Cheung, M
    Heise, N
    Dowdy, A
    DeAngelis, D
    Fisher, LD
    Albers, J
    CANADIAN JOURNAL OF CARDIOLOGY, 1998, 14 : 6A - 13A
  • [9] Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study)
    Ballantyne, Christie M.
    Davidson, Michael H.
    McKenney, James
    Keller, Laurence H.
    Bajorunas, Daiva R.
    Karas, Richard H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (10): : 1428 - 1436
  • [10] Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)
    Zhao, XQ
    Morse, JS
    Dowdy, AA
    Heise, N
    DeAngelis, D
    Frohlich, J
    Chait, A
    Albers, JJ
    Brown, BG
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (03): : 307 - 312
123